Professor Behar-Cohen has received awards for her research, including the Research Prize of the French Society of Ophthalmology, and is a member of numerous societies and scientific commissions. She is a member of the editorial board of Molecular Vision and the Journal of Ocular Pharmacology and Therapeutics, TVST, Progress Retinal Eye Research and has published over 190 articles and a dozen books or book chapters.

Professor Behar-Cohen’s research interests include the development of innovative treatments and methods of administration for drugs in the eye, particularly for diseases of the retina, and mechanisms of action of steroids and anti-VEGFs in the retina. She has introduced the use of mineralocorticoid receptor antagonists for the treatment of central serous chorioretinopathy.